Discontinued — last reported Q4 '25

Investing

Acquisitions

Year-over-year, this metric declined by 100.0%, from $17.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 86.2% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: cf_acquisitions

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$3.00M$3.00M$3.00M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00-$0.00-$0.00$0.00$17.00M$127.38M$0.00$0.00$0.00
QoQ Change+0.0%+0.0%-100.0%+649.2%-100.0%
YoY Change-100.0%-100.0%-100.0%-100.0%
Range-$0.00$127.38M
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Teradyne, Inc.'s acquisitions?
Teradyne, Inc. (TER) reported acquisitions of $0.00 in Q1 2026.
How has Teradyne, Inc.'s acquisitions changed year-over-year?
Teradyne, Inc.'s acquisitions decreased by 100.0% year-over-year, from $17.00M to $0.00.
What is the long-term trend for Teradyne, Inc.'s acquisitions?
Over 4 years (2021 to 2025), Teradyne, Inc.'s acquisitions has grown at a 86.2% compound annual growth rate (CAGR), from $12.00M to $144.38M.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.